LONDON and AUSTIN, Texas, March 30, 2021 /PRNewswire/ — For the past year, Blue Prism®, a global leader in intelligent automation, has donated resources to those most in need during the pandemic as part of its COVID-19 Response Program. COVID-19 struck industries quickly and with force and it was imperative that solutions were deployed rapidly to meet the challenges head on.
Blue Prism’s AI-powered robots have been at the forefront of this effort. By relieving humans from resource-heavy and time-consuming processes, Blue Prism technology has enabled workers to focus on what really matters – high value, customer-centric care. Helping organizations across 14 industries so far, the program has been instrumental in keeping health workers stay safe with PPP supplies, helping small businesses stay afloat and people keep their jobs through accelerating loan applications, making it easier to record and report on essential statistics and in facilitating the remarkable effort to get vaccines in arms.
“From supporting front line health workers to maintaining business continuity in uncertain times, we are honored to have been able to give something back. Providing support through technology was an obvious way for us to help during this crisis, as we transitioned online to cope with the challenges that we all faced.” says Jon Theuerkauf, chief customer strategy & transformation officer, Blue Prism.
The Response Program has donated more than 500 licenses, with a value of more than £4m worth of software, to help organizations under strain become more efficient and capable in handling the operational challenges they face. On average, across more than 60 projects, 8,000 hours have been saved by these organizations (equating to more than three years in human hours worked) per project, representing millions of pounds of financial return.
Through the donation of digital worker software licenses and services, organizations, who lacked access or means to implement or scale intelligent automation have been able to make use of best-in-breed technology or extend their existing services for free to alleviate the impact of the pandemic.
“Blue Prism’s free services allowed us to support even more teams during the pandemic. We used additional Blue Prism intelligent automation capacity to further alleviate our administrative burden so that our Suffolk Short Breaks team had more time in the field, helping families who needed support. The response program helped us to help others, when they needed it most.” says Richard Small, head of intelligent automation, Suffolk County Council.
Blue Prism is still helping organizations by donating digital worker licenses and services. Find out more about how you can apply to the COVID-19 Response Program.
Notes to editors:
About Blue Prism
Blue Prism is the global leader in intelligent automation for the enterprise, transforming the way work is done. At Blue Prism, we have users in over 170 countries in more than 2,000 businesses, including Fortune 500 and public sector organizations, that are creating value with new ways of working, unlocking efficiencies, and returning millions of hours of work back into their businesses. Our digital workforce is smart, secure, scalable and accessible to all; freeing up humans to re-imagine work. Blue Prism’s vision is to provide a digital workforce for every enterprise. To learn more visit www.blueprism.com and follow us on Twitter @blue_prism and on LinkedIn.
© 2020 Blue Prism Limited. “Blue Prism”, the “Blue Prism” logo and Prism device are either trademarks or registered trademarks of Blue Prism Limited and its affiliates. All Rights Reserved.
View original content to download multimedia:http://www.prnewswire.com/news-releases/technology-with-heart-blue-prisms-covid-19-impact-301257606.html
SOURCE Blue Prism
The publication includes a subset of data from the ACTION PMR stroke study and provides…
IRVINE, Calif.--(BUSINESS WIRE)--To ensure that Politan lies repeated over and over are not taken as…
WAYNE, NJ / ACCESSWIRE / July 15, 2024 / Complete Care Lakeview, a leading provider…
Pre-clinical study to explore use of MODD1 pump as a delivery system for FDA-approved, short…
Testing confirms MIRA's preliminary beliefs regarding potential treatment for neurological and neuropsychiatric disorders MIAMI, FL…
ORLANDO, FL / ACCESSWIRE / July 15, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of…